Viatris Inc (VTRS) stock
VTRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/309% below fair value
$20.45−0.29 (-1.40%)
Close on Nov 17, 2026Market cap $23.49BP/E –Yield 2.35%
Viatris pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Viatris's pe ratio was 566.3× on Jan 29, 2021, against 31.5× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2021 | Jan 29, 2021 | 566.3× | −58.3 |
| 2020 | Dec 31, 2020 | 624.7× | +595.1 |
| 2019 | Dec 31, 2019 | 29.6× | – |
See a number that looks wrong?